Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOSEPH A DIPOALA

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1639124605
CMS profile
118955
Location
ROCHESTER, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$1,820.24

130 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,805.89 128
Education $14.35 2

By paying entity

PY2019 · entire year · sorted by reported total

Page 3 of 3; records 101–130 of 130 matching records. This page contains 30 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOSEPH A DIPOALA

NPI 1639124605 · CMS profile ID 118955

Allopathic & Osteopathic Physicians / Internal Medicine

ROCHESTER, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–130 of 130 matching records. This page contains 30 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1639124605?year=2019&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOSEPH A DIPOALA, NPI 1639124605, CMS profile ID 118955. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–130 of 130 matching records. This page contains 30 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1639124605?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). JOSEPH A DIPOALA, NPI 1639124605, CMS profile ID 118955. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–130 of 130 matching records. This page contains 30 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1639124605?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
JOSEPH A DIPOALA, NPI 1639124605, CMS profile ID 118955, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–130 of 130 matching records. This page contains 30 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1639124605?year=2019&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

130 matching records · $1,820.24 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 130 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–130 of 130.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme Corporation $12.5703/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695338213 CMS
Abbott Laboratories $22.5103/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 664392571 CMS
AstraZeneca Pharmaceuticals LP $15.8403/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685236963 CMS
Novartis Pharmaceuticals Corporation $20.5603/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659001419 CMS
Lilly USA, LLC $12.2802/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657917077 CMS
Lilly USA, LLC $0.4302/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657917079 CMS
Lilly USA, LLC $0.4602/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657913479 CMS
Lilly USA, LLC $15.5402/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657924447 CMS
PFIZER INC. $1.2002/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673119427 CMS
GlaxoSmithKline, LLC. $14.5802/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671343897 CMS
Novo Nordisk Inc $11.0602/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 668743899 CMS
Shire North American Group Inc $11.2502/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637814031 CMS
AstraZeneca Pharmaceuticals LP $14.1202/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685918561 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $11.6602/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684710887 CMS
Janssen Pharmaceuticals, Inc $12.4602/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658518525 CMS
AstraZeneca Pharmaceuticals LP $6.0002/13/2019 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685786593 CMS
GlaxoSmithKline, LLC. $12.3702/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670984745 CMS
Amgen Inc. $20.7002/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662564767 CMS
Janssen Pharmaceuticals, Inc $26.2302/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658518521 CMS
PFIZER INC. $14.4002/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673115657 CMS
Merck Sharp & Dohme Corporation $11.3701/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695246357 CMS
PFIZER INC. $7.9601/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673119731 CMS
AstraZeneca Pharmaceuticals LP $9.4001/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685188427 CMS
AstraZeneca Pharmaceuticals LP $13.3701/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685501155 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.0401/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684710885 CMS
Novo Nordisk Inc $16.0701/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 668743901 CMS
PFIZER INC. $15.3901/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673116835 CMS
Lilly USA, LLC $12.2001/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657906709 CMS
Lilly USA, LLC $1.2901/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657927859 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.5901/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684710883 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,820.24 130
PY2020 $807.52 39
PY2021 $994.62 55
PY2022 $417.81 23
PY2023 $3,477.97 10

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2022 Principal investigator $23,799.90 17

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

17 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Alnylam Pharmaceuticals Inc. $30.00 12/30/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131297
Principal investigator 1 Alnylam Pharmaceuticals Inc. $55.00 12/30/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131299
Principal investigator 1 Alnylam Pharmaceuticals Inc. $55.00 12/30/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131301
Principal investigator 1 Alnylam Pharmaceuticals Inc. $3,500.00 12/12/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131291
Principal investigator 1 Alnylam Pharmaceuticals Inc. $2,000.00 12/12/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131293
Principal investigator 1 Alnylam Pharmaceuticals Inc. $2,500.00 12/12/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131295
Principal investigator 1 Alnylam Pharmaceuticals Inc. $2,000.00 12/02/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131287
Principal investigator 1 Alnylam Pharmaceuticals Inc. $12,000.00 12/02/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131289
Principal investigator 1 Alnylam Pharmaceuticals Inc. $405.00 11/30/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131315
Principal investigator 1 Alnylam Pharmaceuticals Inc. $55.00 11/30/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131317
Principal investigator 1 Alnylam Pharmaceuticals Inc. $55.00 11/30/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131319
Principal investigator 1 Alnylam Pharmaceuticals Inc. $70.00 10/31/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131303
Principal investigator 1 Alnylam Pharmaceuticals Inc. $352.00 10/31/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131305
Principal investigator 1 Alnylam Pharmaceuticals Inc. $264.00 10/31/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131307
Principal investigator 1 Alnylam Pharmaceuticals Inc. $264.00 10/31/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131309
Principal investigator 1 Alnylam Pharmaceuticals Inc. $176.00 10/31/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131311
Principal investigator 1 Alnylam Pharmaceuticals Inc. $18.90 10/31/2022 Non-covered Recipient Entity
Rochester Clinical Research,Inc.
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1) No dispute reported 06/30/2026 910131313